Seung-Hoon Lee, MD, PhD, FAHA
CEO
Dr. Seung-Hoon Lee leads OmniParticles, the world's first nanomedicine CDMO and a clinical-phase fill-finish CMO. With a distinguished background in clinical medicine, translational research, and pharmaceutical development, he brings a deep understanding of the challenges in advancing nanoparticle-based therapeutics. He leads the company in delivering integrated, GMP-compliant solutions that help partners advance and scale their programs from drug substance to drug product.
Bong Geun Cha, PhD
CTO
Dr. Bong Geun Cha, CTO and Director of the Corporate Research Institute at OmniParticles, is an expert in chemical engineering with a focus on nanomedicine. He holds a Ph.D. in Chemical Engineering from Sungkyunkwan University and has conducted research at Harvard University. At OmniParticles, he leads innovation and R&D, driving advancements in nanoparticle-based drug development and manufacturing.
Yong-Sun Park, MS
Team Leader at R&D
Yong-Sun Park, M.S. in Chemical and Biological Engineering, has 15+ years of expertise in nanomaterial synthesis and applications. He co-founded and led R&D at a biotech startup on nanoparticle drug delivery for refractory cancers, driving material development, preclinical studies, and regulatory strategy. At OmniParticles, he advances drug discovery and pipeline growth through nanomaterial design, CMC development, and cross-functional R&D.
Tae Eun Kim, MS
Team Leader at R&D
Tae Eun Kim specializes in nanoparticle-based drug development, process optimization, and pilot-scale manufacturing. With expertise in nanoparticle synthesis, molecular diagnostics, and therapeutic formulation, he plays a key role in advancing nanomedicine innovations.
GunJu Sun, PhD
GMP & CMC Specialist
GunJu Sun specializes in nanomaterial synthesis, process optimization, and quality control in pharmaceutical manufacturing. With expertise in CMC, he ensures compliance with GMP standards and enhances the efficiency of nanoparticle-based drug production. His background in materials science and engineering supports the development of high-quality nanomedicines.
Yong-Sung Jeon
GMP Specialist
Yong-Sung Jeon brings nearly 8 years of experience in animal nutrition and manufacturing operations. He supports GMP compliance through SOP development, equipment qualification, and cleanroom operations.
Jaewon Lee
CMC Specialist
Jaewon Lee supports CMC development with expertise in pharmaceutical sciences and biochemistry. With experience in anticancer drug research and analytical method development, he ensures the stability and quality of drug substances while supporting cGMP compliance and regulatory documentation.